Get started
Author

Karen W. Hoover

Observed names: K Hoover, K W Hoover, K. W. HOOVER, K. W. Hoover, K.W. Hoover, Karen Hoover, Karen W Hoover
Observed institutions: Centers for Disease Control and Prevention, San Francisco General Hospital, United States Department of Health and Human Services, New York City Department of Health and Mental Hygiene, Johns Hopkins University, Pfizer (United States), Johns Hopkins Medicine, University of Alabama at Birmingham, University of Illinois Chicago, Indiana State Department of Health, Centers for Disease Control and Prevention, District of Columbia Department of Health, National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, National Opinion Research Center, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services, Thrive, DLH Corporation (United States)
ORCID: 0000-0003-4942-7905
Observed ORCID: 0000-0003-4942-7905
OpenAlex ID: A5035308828
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
2016 · Philip J. Peters, Pamela Pontones, et al. · New England Journal of Medicine · 594
PDF
HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
2018 · Ya-lin A. Huang, Weiming Zhu, et al. · MMWR Morbidity and Mortality Weekly Report · 420
PDF
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone—Indiana, 2015
2015 · Caitlin Conrad, Heather M Bradley, et al. · Annals of Emergency Medicine · 361
PDF
Trends in the Diagnosis and Treatment of Ectopic Pregnancy in the United States
2010 · Karen W. Hoover, Guoyu Tao, et al. · Obstetrics and Gynecology · 228
Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study
2017 · Samuel M Jenness, Kevin M Weiss, et al. · Clinical Infectious Diseases · 225
PDF
Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States
2016 · Samuel M. Jenness, Steven M. Goodreau, et al. · The Journal of Infectious Diseases · 195
Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis
2024 · Patrick S. Sullivan, Stephanie N. DuBose, et al. · The Lancet Regional Health - Americas · 127
PDF
Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons—United States, 2010–2014
2016 · Hsiu Wu, Maria C. B. Mendoza, et al. · Clinical Infectious Diseases · 126
PDF
Performance of Treponemal Tests for the Diagnosis of Syphilis
2018 · Ina U Park, Yetunde F Fakile, et al. · Clinical Infectious Diseases · 122
Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review
2019 · Erin Bradley, Kaitlin Forsberg, et al. · Journal of Women s Health · 106
STD Screening of HIV-Infected MSM in HIV Clinics
2010 · Karen W. Hoover, Mary Butler, et al. · Sexually Transmitted Diseases · 105
Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States
2018 · Samuel M Jenness, Kevin M Maloney, et al. · American Journal of Epidemiology · 104
PDF
Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States, 2012–2017
2020 · Ya-Lin A Huang, Guoyu Tao, et al. · Clinical Infectious Diseases · 83
PDF
Provider Barriers Prevent Recommended Sexually Transmitted Disease Screening of HIV-Infected Men Who Have Sex With Men
2014 · Jarvis W. Carter, Geoffrey D. Hart-Cooper, et al. · Sexually Transmitted Diseases · 73
Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012–2016
2020 · Dawn K Smith, Patrick S Sullivan, et al. · Clinical Infectious Diseases · 62
Identification of pregnancies and their outcomes in healthcare claims data, 2008–2019: An algorithm
2023 · Elizabeth C. Ailes, Weiming Zhu, et al. · PLoS ONE · 58
PDF
HIV Services and Outcomes During the COVID-19 Pandemic — United States, 2019–2021
2022 · Karen W. Hoover, Weiming Zhu, et al. · MMWR Morbidity and Mortality Weekly Report · 57
PDF
Low Rates of Hepatitis Screening and Vaccination of HIV-Infected MSM in HIV Clinics
2012 · Karen W. Hoover, Mary Butler, et al. · Sexually Transmitted Diseases · 56
Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act
2015 · Karen W. Hoover, Bradley W. Parsell, et al. · American Journal of Public Health · 52
Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States—A Time-Series Analysis
2022 · Ya Lin A Huang, Weiming Zhu, et al. · Clinical Infectious Diseases · 51
Improving HIV Preexposure Prophylaxis Implementation for Women: Summary of Key Findings From a Discussion Series with Women's HIV Prevention Experts
2018 · Erin L.P. Bradley, Karen W. Hoover · Women s Health Issues · 51
PDF
Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010–2017
2020 · Lara Bull-Otterson, Ya-Lin A Huang, et al. · The Journal of Infectious Diseases · 49
Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals
2020 · Samuel M. Jenness, Jordan A. Johnson, et al. · AIDS · 48
PDF
Infective Endocarditis Among Persons Aged 18–64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007−2017
2020 · Cecillia Y Wong, Weiming Zhu, et al. · Clinical Infectious Diseases · 47
PDF
Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010.
2014 · Karen W Hoover, Jami S Leichliter, et al. · PubMed · 47
Works count: 166
Citation count: 4,919
H-index: 33
I10-index: 84
Year
Topic
Type